NYLI WMC Value Class I (MUBFX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
32.60
+0.12 (0.37%)
Jun 3, 2025, 4:00 PM EDT
3.39% (1Y)
| Fund Assets | 1.03B |
| Expense Ratio | 1.37% |
| Min. Investment | $1,000,000 |
| Turnover | n/a |
| Dividend (ttm) | 1.67 |
| Dividend Yield | 5.13% |
| Dividend Growth | 22.99% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 9, 2024 |
| Previous Close | 32.48 |
| YTD Return | 2.45% |
| 1-Year Return | 8.60% |
| 5-Year Return | 89.26% |
| 52-Week Low | 29.19 |
| 52-Week High | 35.72 |
| Beta (5Y) | n/a |
| Holdings | 70 |
| Inception Date | Jan 21, 1971 |
About MUBFX
The NYLI WMC Value Class I (MUBFX) seeks to earn income as a secondary objective. MUBFX normally invests at least 65% of its total assets in equity-type securities.
Fund Family MainStay Fds I
Category Large Value
Performance Rating Above Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol MUBFX
Share Class Class I
Index Russell 1000 Value NR
Performance
MUBFX had a total return of 8.60% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.73%.
Top 10 Holdings
24.78% of assets| Name | Symbol | Weight |
|---|---|---|
| UnitedHealth Group Incorporated | UNH | 3.78% |
| JPMorgan Chase & Co. | JPM | 3.78% |
| Johnson & Johnson | JNJ | 3.19% |
| Cisco Systems, Inc. | CSCO | 2.43% |
| Elevance Health, Inc. | ELV | 2.17% |
| American International Group, Inc. | AIG | 2.11% |
| Pfizer Inc. | PFE | 1.93% |
| Gilead Sciences, Inc. | GILD | 1.85% |
| ConocoPhillips | COP | 1.78% |
| MetLife, Inc. | MET | 1.77% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2024 | $1.66748 | Dec 9, 2024 |
| Dec 6, 2023 | $1.35577 | Dec 6, 2023 |
| Dec 7, 2022 | $1.67837 | Dec 7, 2022 |
| Dec 2, 2021 | $25.90776 | Dec 2, 2021 |
| Dec 2, 2020 | $1.77383 | Dec 2, 2020 |
| Dec 2, 2019 | $3.61023 | Dec 2, 2019 |